Following are the day’s biggest winners and losers. Find out why shares of Google and Campbell Soup popped while New York Times and Hess dropped.   Read More

Five stocks, huge yields, great defense against this volatile market.   Read More

Telcos, pharmas and some media stocks present investment opportunities now, according to Fergus O'Sullivan, managing director at Morgan Stanley.   Read More

Following are the day’s biggest winners and losers. Find out why shares of JM Smucker and Tyson Foods popped while Astra-Zeneca and Freeport-McMoRan dropped.   Read More

When drug companies choose bullish, optimistic-sounding acronyms for clinical trials they should, perhaps, choose more wisely lest they backfire when the tests don't turn out like they hope they will. Witness what happened this morning to AstraZeneca.    Read More

One of the weapons widely used to fight cholesterol might be more powerful than previously believed. Is there a trade here?   Read More

Like anxious relatives in a hospital room, investors have been watching the economy get sicker and sicker with new symptoms surfacing daily.   Read More

Even before the results of the election were official there was already speculation in the blogosphere about who might become the next Commissioner of the Food and Drug Administration under a President Obama.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Yahoo! and Safeway popped while Barclays and eBay dropped.   Read More

I could easily blog about how badly biopharma is performing in this bear market, how all of the big pharma stocks hit new lows this morning with the lone exception of AstraZeneca.    Read More